Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

BACKGROUND: For patients with type 2 diabetes who are uncontrolled on a combination of two oral antidiabetic agents, addition of the long-acting basal insulin glargine is a well established treatment option. However, data on the efficacy and safety of a combination of metformin, a dipeptidyl peptida...

Descripción completa

Detalles Bibliográficos
Autores principales: Seufert, Jochen, Pegelow, Katrin, Bramlage, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833837/
https://www.ncbi.nlm.nih.gov/pubmed/24259985
http://dx.doi.org/10.2147/VHRM.S54362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833837/
https://www.ncbi.nlm.nih.gov/pubmed/24259985
http://dx.doi.org/10.2147/VHRM.S54362

Ejemplares similares